SCM
LUXA

Saba Capital Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Saba Capital Management’s Portfolio LUXA Stock Details LUXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,027,240
Closed -$10.3M – 1168
2022
Q3 		$10.3M Hold
1,027,240
– – 0.12% 330
2022
Q2 		$10.2M Buy
1,027,240
+451,200
+78% +$4.46M 0.12% 320
2022
Q1 		$5.68M Buy
+576,040
New +$5.66M 0.08% 408

Saba Capital Management's LUXA Position: Q4 2022 in Review

Saba Capital Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 1,027,240 shares — an estimated $10.3M sold.

Saba Capital Management first reported a position in LUXA in Q1 2022 and held it in 3 quarters. The position peaked at $10.3M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Saba Capital Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Saba Capital Management sold 1,027,240 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $10.3M.
  • Saba Capital Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Saba Capital Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $10.3M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.